U.S. Software Stock News

NYSEAM:UEC
NYSEAM:UECOil and Gas

Uranium Energy (UEC) Valuation Check As Burke Hollow Becomes First New US ISR Uranium Mine In Over A Decade

Uranium Energy (UEC) has kicked off production at its Burke Hollow in situ recovery uranium mine after securing approval from the Texas Commission on Environmental Quality, creating the first new U.S. ISR operation in more than a decade. See our latest analysis for Uranium Energy. The latest production milestone comes after a 19.5% 1 month share price return and a 10.2% year to date share price gain, set against a 1 year total shareholder return of around 3x. This suggests strong long term...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed?

On April 14, 2026, Harmony Biosciences Holdings, Inc. appointed veteran biopharmaceutical executive Glenn Reicin as Chief Financial Officer and Executive Team member, while reiterating its 2026 net product revenue guidance of US$1.00 billion to US$1.04 billion. This combination of a new finance leader with deep capital markets experience and maintained revenue expectations points to an emphasis on execution, capital discipline, and continuity in the company’s growth plans. We’ll now examine...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Assessing Ally Financial (ALLY) Valuation After Earnings Beat And Return To Profitability

Ally Financial (ALLY) has moved back into focus after reporting first quarter 2026 results that returned the bank to profitability, with higher net interest income, positive net income, and earnings per share back in positive territory. See our latest analysis for Ally Financial. Ally Financial's recent 18.92% 1 month share price return and 50.22% 1 year total shareholder return suggest momentum has picked up again, as investors react to the earnings beat, restored profitability, and...
NYSE:NKE
NYSE:NKELuxury

Is It Time To Reassess Nike (NKE) After Its Multi Year Share Price Pullback

If you are wondering whether NIKE's share price still reflects its brand strength or if the market is mispricing it, the next sections will walk through the numbers in a clear and practical way. NIKE last closed at US$46.39, with a 5.0% gain over the past week, an 11.4% decline over 30 days, and returns of 26.7% decline year to date and 16.7% decline over the last year. It has also seen deeper 3-year and 5-year pullbacks of 60.6% and 62.1% respectively. These moves have put valuation back in...
NYSE:HRB
NYSE:HRBConsumer Services

A Look At H&R Block (HRB) Valuation After A Year Of Weak Shareholder Returns

H&R Block stock snapshot after recent performance trends H&R Block (HRB) has drawn attention after mixed share performance, with a one-month gain of 1.6% contrasting with a 20.3% decline over the past three months and a 44.1% drop over the past year. See our latest analysis for H&R Block. Recent trading has shown a short bounce in the share price, with a 1-day share price return of 1.86% and 7-day return of 5.83%. However, this sits against a weaker backdrop that includes a 90-day share price...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Robinhood OpenAI Stake Highlights New Private Tech Access And Valuation Risk

Robinhood Markets, NasdaqGS:HOOD, has committed $75 million from its Ventures Fund I to invest in OpenAI. The investment is intended to widen access for retail investors to large private tech companies that are usually limited to institutions. This move expands Robinhood’s product set beyond trading and cash management into private market exposure. Robinhood Markets is drawing attention with this new OpenAI stake, using its recently launched Ventures Fund I to move further into private...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Has PDF Solutions (PDFS) Run Too Far After 154% One Year Share Price Jump?

If you are trying to work out whether PDF Solutions at around US$43.61 still offers value, the recent share price performance raises some timely questions about what you are really paying for. The stock has posted returns of 5.5% over the last 7 days, 33.1% over the past month, 47.6% year to date and 154.1% over the last year. This naturally puts the focus on whether these moves are supported by fundamentals or changing risk perceptions. Recent commentary around PDF Solutions has largely...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Is Blackbaud (BLKB) Now Priced For A Turnaround After Prolonged Share Price Weakness?

Wondering whether Blackbaud at US$38.62 is now priced for a turnaround or still reflecting old concerns? This article breaks down what that current tag might really imply for you. The stock has had a mixed run, with a 7.6% gain over the last 7 days, a 12.5% decline over 30 days, and year to date and 1 year returns of 35.1% and 37.1% declines, while the 3 year and 5 year returns sit at 41.8% and 46.4% declines. Recent share price moves are part of a longer stretch where Blackbaud has lagged...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (NasdaqGS:GOOGL) Valuation Check After Recent 10% Monthly Share Price Gain

Alphabet stock overview after recent performance Alphabet (GOOGL) has drawn fresh attention after a recent period in which the stock shows a monthly gain of about 10% and a modest return over the past 3 months, prompting investors to reassess its profile. See our latest analysis for Alphabet. At a share price of $332.29, Alphabet’s recent 10.4% 1 month share price return and strong 1 year total shareholder return of 120.14% point to momentum that has built meaningfully over time. If strong...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation Rigaku Deal Targets Hybrid Metrology Growth In Process Control

Onto Innovation (NYSE:ONTO) announced a collaboration with Rigaku Holdings Corporation focused on next generation semiconductor process control solutions. As part of the agreement, Onto is investing $710 million for a 27% equity stake in Rigaku and gains the right to nominate a director. The partnership combines Onto's AI enabled metrology software with Rigaku's X ray technologies to target hybrid metrology for advanced logic and memory manufacturing. For investors tracking NYSE:ONTO, this...
NYSE:CVX
NYSE:CVXOil and Gas

Should Chevron’s New Bandit Find and Venezuela Tailwinds Reshape CVX’s Geopolitical Risk Profile?

In recent days, Chevron confirmed an oil discovery at the Bandit prospect in the Gulf of America and, against the backdrop of Iran’s closure of the Strait of Hormuz and shifting Venezuelan politics, has become more central to discussions about non‑Middle East supply security and potential Venezuelan output growth. These developments, alongside analyst upgrades and legal wins, highlight how Chevron’s global footprint and legal positioning may influence its role in meeting re-routed energy...
NYSE:GE
NYSE:GEAerospace & Defense

GE Q1 Earnings Steady While 24.2% TTM Profit Growth Tests Bullish Narratives

General Electric (GE) opened 2026 with Q1 revenue of US$12.4b and basic EPS of US$1.84, setting the tone for how the year is starting to shape up after a strong 2025 earnings run. The company has seen quarterly revenue move from US$9.9b in Q1 2025 to US$12.4b in Q1 2026, while basic EPS has stayed in a tight band around the mid US$1 range. This puts more attention on how efficiently that top line is being converted into profit. Against that backdrop, investors are likely to focus on how...
NYSE:ESE
NYSE:ESEMachinery

A Look At ESCO Technologies (ESE) Valuation After A Powerful Multi Year Share Price Run

Recent share performance and business snapshot ESCO Technologies (ESE) shares have attracted attention after a strong run over the past month and past 3 months, prompting investors to reassess the company’s mix of aerospace, utility, and RF testing businesses. The Saint Louis based group reports revenue of US$1,170.454 million and net income of US$124.683 million, with operations spanning Aerospace & Defense, Utility Solutions Group, and RF Test & Measurement across primarily United States...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Assessing Celldex Therapeutics (CLDX) Valuation After Strong Recent Share Price Gains

Celldex Therapeutics stock snapshot Celldex Therapeutics (CLDX) has drawn investor attention after recent gains, with the share price at $34.25 and total return figures of 10.8% over the past month and 30.9% over the past 3 months. See our latest analysis for Celldex Therapeutics. Short term momentum has been firm, with a 30 day share price return of 10.8% and a 90 day gain of 30.9%, while the 1 year total shareholder return of 76.6% reflects a strong recent run compared with its longer term...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Microsoft Faces UK Cloud Lawsuit As Xbox Subscription Model Evolves

Microsoft (NasdaqGS:MSFT) is facing a UK mass lawsuit alleging it overcharged tens of thousands of British businesses for running Windows Server on rival cloud platforms. A UK tribunal has ruled that the antitrust case can proceed, bringing fresh scrutiny to Microsoft’s European cloud pricing practices. Separately, Microsoft has changed its Xbox Game Pass approach, cutting prices on key tiers and delaying the addition of new Call of Duty titles to the service. The Xbox move is one of the...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Offering An Opportunity After A 53% One Year Share Price Slide

How recent returns frame the Molina Healthcare valuation story Molina Healthcare’s share price has been through a rough patch, so it helps to step back and look at how the recent returns set the scene for a closer look at what the stock might be worth. Over the last year the stock recorded a 53.0% loss, with a year to date return of 15.4% decline, even though the past 7 days and 30 days show positive returns of 2.4% and 8.3% respectively from a last close of US$151.00. Recent coverage of...
NYSE:JCI
NYSE:JCIBuilding

Is It Too Late To Consider Johnson Controls International (JCI) After Its Strong 1‑Year Rally?

If you are wondering whether Johnson Controls International at around US$139.72 is offering fair value or stretching expectations, you are not alone. The stock has seen a 1.6% decline over the last 7 days, while returns sit at 7.7% over 30 days, 14.2% year to date, 84.9% over 1 year, 154.0% over 3 years and 143.9% over 5 years. Recent coverage has focused on Johnson Controls International as a key player in building technologies and energy efficient solutions. This helps explain why...
NYSE:ELV
NYSE:ELVHealthcare

Is It Time To Revisit Elevance Health (ELV) After Recent Share Price Weakness

Wondering whether Elevance Health at around US$328 is starting to look like value or still priced for high expectations? This article walks through what the numbers actually say about the stock. The share price closed at US$328.11, with returns of 4.7% over 7 days and 12.6% over 30 days. This is set against a 7.4% decline year to date and a 19.4% decline over the last year. These moves come as Elevance Health continues to sit at the center of US healthcare. Investors are closely watching how...
NYSE:NRG
NYSE:NRGElectric Utilities

Does NRG (NRG)ʼs New US$3.1 Billion Debt Shuffle Redefine Its Income Investor Appeal?

In April 2026, NRG Energy, Inc. completed several large debt financings totaling about US$3.10 billion across secured and unsecured notes, while also affirming a quarterly dividend of US$0.4750 per share payable on May 15, 2026. By refinancing existing borrowings and targeting higher-cost Lightning Power notes with this new funding, NRG is actively reshaping its capital structure and interest obligations, a key consideration for income-focused and credit-sensitive investors. Against this...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

A Look At Phillips Edison (PECO) Valuation After Robust 2025 Results And 2026 Growth Guidance

Phillips Edison (PECO) has drawn fresh attention after reporting robust 2025 results, including growth in NAREIT FFO per share and same-center NOI, along with guidance for mid-single digit earnings growth in 2026. See our latest analysis for Phillips Edison. The latest results and guidance appear to be contributing to a strengthening trend, with a 30 day share price return of 5.62% and a year to date share price return of 10.24%. The 5 year total shareholder return of 146.86% points to a...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Southern Copper (SCCO) Is Down 5.1% After CEO’s Sudden Passing Amid Megaproject Push - What's Changed

Southern Copper Corporation announced that President and CEO Oscar Gonzalez Rocha, who also served on the Board, passed away unexpectedly on April 7, 2026, and the Board plans to appoint a successor or interim CEO. His sudden passing removes a long-tenured leader at a time when Southern Copper is committing over US$15.00 billion to large, multi-year expansion projects. We will now examine how this sudden leadership transition, amid heavy long-term investment commitments, could influence...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Is It Time To Reconsider BioMarin Pharmaceutical (BMRN) After Multi Year Share Price Weakness

Investors may be wondering whether BioMarin Pharmaceutical's share price lines up with its underlying value, especially after a mixed run for the stock. At a last close of US$54.62, the stock has recorded a 1.5% decline over 7 days, is up 0.9% over 30 days, but is still showing returns of an 8.1% decline year to date and an 11.2% decline over 1 year. These moves sit against a longer backdrop of weaker returns, with 3-year returns at a 42.8% decline and 5-year returns at a 31.5% decline. For...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

A Look At Mercury Systems (MRCY) Valuation After A Strong One Year Shareholder Return

Event context and recent share performance Mercury Systems (MRCY) has been drawing investor attention after a period of mixed share performance, with a gain over the past month but weaker returns in the past 3 months and recent daily trading softness. See our latest analysis for Mercury Systems. At the current share price of $83.36, Mercury Systems shows a 30 day share price return of 7.9%, a 90 day share price return of 16.3%, and a 1 year total shareholder return of 73.8%. If this kind of...